The frequency of pulmonary hypertension in chronic obstructive pulmonary disease of geriatric patients: a narrative literature review

被引:1
|
作者
Luca, Ecaterina [1 ]
Bodrug, Nicolae [1 ]
机构
[1] State Univ Med & Pharm Nicolae Testemitanu, Dept Internal Med Discipline Geriatr & Occupat Med, Kishinev, Moldova
来源
EGYPTIAN JOURNAL OF INTERNAL MEDICINE | 2022年 / 34卷 / 01期
关键词
Pulmonary hypertension; Chronic obstructive pulmonary disease; Geriatric patients; Acute exacerbation; Echocardiography; ECHOCARDIOGRAPHY; PREVALENCE; DIAGNOSIS;
D O I
10.1186/s43162-022-00135-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary hypertension (PH) is a serious complication with complex pathogenesis in the natural history of chronic obstructive pulmonary disease COPD, with a progressively increasing frequency with a meanwhile decreasing in functional capacity. Purpose: Assessment of the incidence, pathogenesis, peculiarities, and complications of PH in COPD in geriatric population worldwide. Methods: We performed an analysis of randomized, retrospective, and prospective clinical, case-control and observational studies, published at the international level, according to the subject studied and target population. Four hundred ninety-seven full articles were identified after the search through engine Google Search and databases PubMed, Hinari, SpringerLink, and Scopus (Elsevier) according to the keywords and subsequent filters. Results: Depending on various factors, like the population examined, the definition used for mPAP (mPAP> 20 mm Hg or >= 25 mm Hg), the severity of the lung disease, and the method of measuring PAP, a varied incidence of COPD patients with PH complication was discovered, namely 10-91%. PH prevalence increases with the COPD severity. The presence of PH is associated with acute exacerbations of COPD, reduced survival, and increasing expenses for healthcare programs. Mild to moderate levels of PH (mPAP 25-34 mm Hg) are relatively common in COPD and usually are associated with severe airflow obstruction or parenchymal destruction. Only a minority of patients (1-5%) have severe PH (mPAP >= 35 mm Hg). Conclusions: Diagnosis of PH in COPD is difficult, especially in a mild form, and requires a clinical approach associated with a comprehensive set of investigations for confirming the etiology, evaluation of the functional and hemodynamical impairment severity, and important factors in the appropriate treatment election.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Effects of Trimetazidine on Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension.
    Chung, J. H.
    Choi, J. E.
    Cho, D. K.
    Oh, S. J.
    Yoon, S. J.
    Han, C. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [32] Uncovering the Bronchovascular Links in Patients with Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension
    Kirby, Miranda
    Coxson, Harvey O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (01) : 8 - 10
  • [33] NOCTURNAL PULMONARY-HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    BOYSEN, PG
    BLOCK, AJ
    WYNNE, JW
    HUNT, LA
    FLICK, MR
    CHEST, 1979, 76 (05) : 536 - 542
  • [34] Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: A literature review
    Cafarella, Paul A.
    Effing, Tanja W.
    Usmani, Zafar-Ahmad
    Frith, Peter A.
    RESPIROLOGY, 2012, 17 (04) : 627 - 638
  • [35] Effects of Pulmonary Hypertension on Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease
    Blanco, Isabel
    Valeiro, Beatriz
    Torres-Castro, Rodrigo
    Barberan-Garcia, Anael
    Torralba, Yolanda
    Moises, Jorge
    Sebastian, Laura
    Osorio, Jeisson
    Rios, Jose
    Gimeno-Santos, Elena
    Roca, Josep
    Barbera, Joan A.
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (08): : 499 - 505
  • [36] Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease Advances in Pathophysiology and Management
    Albert Barbera, Joan
    Blanco, Isabel
    DRUGS, 2009, 69 (09) : 1153 - 1171
  • [37] Study of Pulmonary Hypertension and Its Predictors in Patients with Chronic Obstructive Pulmonary Disease
    Youssef, S.
    El Hoshy, M.
    Gharraf, H.
    El Hoshy, M. S.
    Eshmawey, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [38] LITERATURE REVIEW OF RISK FACTORS FOR MORTALITY OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Cheng, Y.
    Raisch, D. W.
    Roberts, M.
    VALUE IN HEALTH, 2011, 14 (03) : A137 - A137
  • [39] Integrative literature review on treatment management in patients with chronic obstructive pulmonary disease
    dos Santos Castro Padilha, Jose Miguel
    dos Santos Oliveira, Manuel Fernando
    Alves Campos, Maria Joana
    REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2010, 44 (04) : 1123 - 1128
  • [40] Manual Therapy Interventions in Patients With Chronic Obstructive Pulmonary Disease: A Comprehensive Narrative Review
    Chilhate, Priyanka K.
    Lalwani, Lajwanti
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)